Precision Biosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Precision Biosciences Inc
TickerDTIL
CIK #0001357874
CUSIP74019P108
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address302 East Pettigrew Street Suite A-100, Durham, NC 27701
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Precision Biosciences Inc 2019-03-15 39.5 M Exemption: 506(b) · Remaining: $30,450,000 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001357874] 10-K
[0001357874] 10-Q
[0001357874] 3
[0001357874] 4
[0001357874] 8-K
[0001357874] D
[0001357874] SC 13D
[0001357874] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Lynx1 Capital Management LP Precision Biosciences Inc [2026-07-20] 0.0
Octagon Capital Advisors LP Precision Biosciences Inc [2026-02-10] 0.0
Aberdeen Group PLC Precision Biosciences Inc [2026-01-27] 0.0
Empery Asset Management LP Precision Biosciences Inc [2026-01-22] 0.0
Bleichroeder LP Precision Biosciences Inc [2025-08-14] 0.0
Readout Capital LP Precision Biosciences Inc [2025-03-26] 0.0
Weinstein Benjamin Precision Biosciences Inc [2025-03-18] 0.0
Lynx1 Capital Management LP Precision Biosciences Inc [2025-02-14] 0.0
Highbridge Capital Management LLC Precision Biosciences Inc [2024-11-14] 5.3
Aquilo Capital Management LLC Precision Biosciences Inc [2024-03-18] 7.1
Perceptive Advisors LLC Precision Biosciences Inc [2024-03-14] 81947.9
Janus Henderson Group PLC Precision Biosciences Inc [2024-03-11] 8.0
Tang Capital Partners LP Precision Biosciences Inc [2024-02-05] 5.2
Great Point Partners LLC Precision Biosciences Inc [2023-02-27] 7.3
BlackRock Inc Precision Biosciences Inc [2022-07-08] 2.4
Great Point Partners LLC Precision Biosciences Inc [2022-07-01] 5.89
Novartis Pharma AG Precision Biosciences Inc [2022-06-27] 16.6
Vanguard Group Inc Precision Biosciences Inc [2022-02-10] 5.34
BlackRock Inc Precision Biosciences Inc [2021-02-02] 7.7
Eli Lilly & Co Precision Biosciences Inc [2021-01-08] 7.165
Jantz Derek Precision Biosciences Inc [2020-02-18] 8.2
Capital World Investors Precision Biosciences Inc [2020-02-14] 7.9
BlackRock Inc Precision Biosciences Inc [2020-02-07] 5.3
venBio Global Strategic Fund LP Precision Biosciences Inc [2019-04-09] 8.7
FMR LLC Precision Biosciences Inc [2019-04-03] 0.0
Form 3/4/5 Filer 2011 - 2026
Pire Shari Lisa
Precision Biosciences Inc
Buehler Kevin
Frankel Stanley
Germano Geno J
Brown Melinda
Smith J Jefferson
Amoroso Michael
Kelly John Alexander
Scimeca Dario
Wadsworth Samuel C
List Alan
Barton Shane
Novartis Pharma AG
Novartis AG
Jantz Derek
Schinazi Raymond F
Thomson David S
Kane Matthew R
Khazi Fayaz
Sharp Shalini
Ansari ABID
Heery Christopher
Yao Tony DUNG Ling
FMR LLC
venBio Global Strategic Fund LP
venBio Global Strategic GP Ltd
Goodman Corey S
venBio Global Strategic GP LP
Adelman Robert J
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Smith J Jefferson
Common Stock
2026-02-18 Sell 4,925 $3.84 18,912
Scimeca Dario
Common Stock
2026-02-18 Sell 4,925 $3.84 18,912
Amoroso Michael
Common Stock
2026-02-18 Sell 20,559 $3.84 78,947
Kelly John Alexander
Common Stock
2026-02-18 Sell 8,149 $3.84 31,292
Amoroso Michael
Common Stock
2026-02-17 Option exercise 67,797 $0.00
Smith J Jefferson
Common Stock
2026-02-17 Option exercise 16,667 $0.00
Kelly John Alexander
Common Stock
2026-02-17 Option exercise 27,584 $0.00
Smith J Jefferson
Restricted Stock Units · derivative
2026-02-17 Option exercise 16,667 $0.00
Amoroso Michael
Restricted Stock Units · derivative
2026-02-17 Option exercise 67,797 $0.00
Scimeca Dario
Restricted Stock Units · derivative
2026-02-17 Option exercise 16,667 $0.00
Scimeca Dario
Common Stock
2026-02-17 Option exercise 16,667 $0.00
Kelly John Alexander
Restricted Stock Units · derivative
2026-02-17 Option exercise 27,584 $0.00
Amoroso Michael
Common Stock
2026-01-22 Sell 34,799 $4.17 145,112
Smith J Jefferson
Common Stock
2026-01-21 Sell 10,200 $4.03 41,106
Kelly John Alexander
Common Stock
2026-01-21 Sell 15,213 $4.03 61,308
Scimeca Dario
Common Stock
2026-01-21 Sell 8,854 $4.03 35,682
Smith J Jefferson
Common Stock
2026-01-21 Option exercise 16,219
Kelly John Alexander
Restricted Stock Units · derivative
2026-01-20 Option exercise 13,900 $0.00
Scimeca Dario
Common Stock
2026-01-20 Option exercise 8,425 $0.00
Amoroso Michael
Restricted Stock Units · derivative
2026-01-20 Option exercise 37,069 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 78 16,170,804
2025-12-31 69 15,106,210
2025-09-30 56 4,649,371
2025-06-30 53 4,480,765
2025-03-31 50 3,786,357
2024-12-31 56 3,879,552
2024-09-30 52 3,323,640
2024-06-30 48 3,161,416
2024-03-31 44 3,196,189
2023-12-31 67 35,807,008
2023-09-30 78 34,746,557
2023-06-30 78 43,803,382
Form 13F Holdings
Firm Period DFND Voting Shares
Beacon Financial Strategies Corp [2026-06-30] SOLE 0 172
Fortitude Family Office LLC [2026-06-30] SOLE 127 127
Farther Finance Advisors LLC [2026-06-30] SOLE 0 10
Investors Research Corp [2026-06-30] SOLE 0 8
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com